JFL Life Sciences Limited IPO
JFL Life Sciences Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹61 per share. The stock debuted at ₹70, delivering a listing gain of 14.8%. The IPO had a lot size of ₹2000 shares and a minimum investment of ₹1,22,000.
JFL Life Sciences Limited IPO
- IPO Dates
- Aug 25, 2022 – Aug 30, 2022
- Price band
- ₹61 per equity share
- Minimum Investment
- ₹1,22,000
- Issue size
- 2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr)
- Lot size
- 2000
- Allotment Date
- Sep 6, 2022
- Listing
- Sep 8, 2022
- Listing At
- NSE SME
IPO timeline
-
Aug 25, 2022
Open Date
Completed
-
Aug 30, 2022
Close Date
Completed
-
Sep 6, 2022
Allotment Date
Completed
-
Sep 8, 2022
Listing Date
Completed
JFL Life Sciences Limited IPO Essentials
JFL Life Sciences Limited IPO Details
JFL Life Sciences Limited IPO is priced at ₹61 per share with a total issue size of 2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr). The IPO has a lot size of 2000 shares and is listed on NSE SME.
- Issue price
- ₹61 per equity share
- Lot size
- 2000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr)
- Listing at
- NSE SME
- List price
- 70.00
- Listing date
- Registrar
- KFin Technologies Limited
- Lead manager
-
GYR Capital Advisors Limited
JFL Life Sciences Limited IPO Analytics
JFL Life Sciences Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
JFL Life Sciences Limited IPO Subscription Status
JFL Life Sciences Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 1,414,000 | 1,414,000 | 2,828,000 |
|
Day 1
25-08-22 06:00 PM
|
(0.24) x | 0.75 x | 0.49 x |
|
Day 2
26-08-22 06:00 PM
|
(0.51) x | 1.65 x | 1.08 x |
|
Day 3
29-08-22 06:00 PM
|
(0.66) x | 3.71 x | 2.19 x |
|
Day 4
30-08-22 06:00 PM
|
(6.19) x | 11.66 x | 8.93 x |
JFL Life Sciences Limited Valuations
Earnings
- EPS (Post IPO)
- ₹0.76/-
Returns
- RoNW
- 7.18%
JFL Life Sciences Limited Financials( In Lakhs)
| 31-Aug-19 | 31-Mar-20 | 31-Mar-21 | 28-Feb-22 | |
|---|---|---|---|---|
| Assets | 1614.96 | 2432.59 | 2900.69 | 3662.86 |
| Revenue | 3177.96 | 3020.41 | 3286.89 | 2563.06 |
| Profit After Tax | 30.25 | 36.04 | 54.21 | 253.28 |
JFL Life Sciences Limited Company & Offer Insights
About JFL Life Sciences Limited
JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
JFL Life Sciences Limited Promoter(s)
Smiral Ashwinkumar Patel, ejal Smiral Patel are the company's promoters of JFL Life Sciences Limited .
JFL Life Sciences Limited IPO Issue Objectives
- •
- Repayment of secured and unsecured loans.
- •
- Funding the working capital requirements of the company.
- •
- General Corporate Purposes
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
JFL Life Sciences Limited IPO is a Fixed Priced IPO worth ₹2,978,000 shares of ₹10(aggregating up to ₹18.17 Cr). The issue price is ₹61 per share (fixed price). The IPO opens on Aug 25, 2022 and closes on Aug 30, 2022. It will be listed on NSE SME Platform. KFin Technologies Limited is the registrar.
The issue price of JFL Life Sciences Limited IPO is ₹61 per share (fixed price).
The lot size of JFL Life Sciences Limited IPO is 2000 shares.
The minimum investment for JFL Life Sciences Limited IPO is approximately ₹1,22,000 based on the issue price .
JFL Life Sciences Limited IPO opens on Aug 25, 2022 and closes on Aug 30, 2022.
The allotment date of JFL Life Sciences Limited IPO is Sep 6, 2022.
JFL Life Sciences Limited IPO is expected to be listed on Sep 8, 2022, on NSE SME Platform.
JFL Life Sciences Limited IPO valuation snapshot: P/E N/A, EPS ₹0.76/-, P/B N/A, RoNW 7.18%, and market cap N/A.
To apply for JFL Life Sciences Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of JFL Life Sciences Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for JFL Life Sciences Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check JFL Life Sciences Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the JFL Life Sciences Limited IPO allotment status on IPO Ji for quick and easy access.